Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.090
-0.290 (-8.58%)
At close: Jun 3, 2026, 4:00 PM EDT
3.110
+0.020 (0.64%)
After-hours: Jun 3, 2026, 7:14 PM EDT

Cellectis Revenue

Cellectis had revenue of $7.55M in the quarter ending March 31, 2026, a decrease of -37.25%. This brings the company's revenue in the last twelve months to $75.11M, up 37.20% year-over-year. In the year 2025, Cellectis had annual revenue of $79.59M with 61.72% growth.

Revenue (ttm)
$75.11M
Revenue Growth
+37.20%
P/S Ratio
3.03
Revenue / Employee
$328,000
Employees
229
Market Cap
227.37M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202579.59M30.38M61.72%
Dec 31, 202449.22M40.02M435.37%
Dec 31, 20239.19M-16.53M-64.26%
Dec 31, 202225.72M-12.87M-33.35%
Dec 31, 202138.60M-20.97M-35.20%
Dec 31, 202059.56M36.57M159.09%
Dec 31, 201922.99M1.56M7.27%
Dec 31, 201821.43M-12.28M-36.43%
Dec 31, 201733.72M-22.73M-40.27%
Dec 31, 201656.45M-6.12M-9.78%
Dec 31, 201562.57M30.56M95.47%
Dec 31, 201432.01M14.51M82.92%
Dec 31, 201317.50M-10.25M-36.93%
Dec 31, 201227.74M7.04M34.00%
Dec 31, 201120.70M-248.60K-1.19%
Dec 31, 201020.95M6.11M41.19%
Dec 31, 200914.84M-2.65M-15.16%
Dec 31, 200817.49M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MacroGenics157.08M
Codexis78.09M
Coherus Oncology46.88M
Adagene7.67M
Entrada Therapeutics5.74M
AC Immune4.62M
SAB Biotherapeutics114.70K
Revenue Rankings